Look at the BioMed website. Look at the PPS of the companies BioMed alerted 2 days previous to the alert. Look at the run up over the next 1-3 days. Look at the big drop/correction after the run ended. Look at the slow bleed back to pre-alert price range if the company didn't issue any material PR's.
IMO, BioMed reports is a trading tool and shouldn't be confused a provider of decent DD. They do have an FDA calendar which is useful, but it's the alerts aspect of BioMed that drives stock prices.
What's more disconcerting is the evidence that BioMed alerts actually leaks their alerts before they are emailed to paid subscribers. I've seen 20-50% rises in PPS on the 1-2 days before getting the alert (I'm a paid subscriber), which strongly suggests that quite a few people are in the know before subscribers.
To reiterate, I'm long here and have held shares closely since .069
I was disappointed that there was no hard news which caused this price spike, as some tangible company event would provide much more support to a PPS rise than an alert from BioMed IMO.